Nvidia’s China Bet Is Back On. Will This Finally Move Its Stock?

Nvidia has restarted H200 AI accelerator production for China after securing U.S. export licenses and Chinese approvals and has already received purchase orders that could add hundreds of millions of dollars in quarterly data-center revenue. China previously accounted for as much as ~20% of Nvidia revenue, so even modest H200 volumes (tens of thousands of units) represent a meaningful near-term revenue bridge while next‑gen Vera Rubin ramps. However, elevated valuation multiples, AI fatigue, and historical inability of single catalysts to break the stock suggest shares may remain range-bound unless order flow and margin expansion are sustained.

Analysis

This China opening functions like a near-term revenue bridge rather than a durable demand inflection — think incremental mid-single-digit percentage points to the next quarter’s data-center sales if order flow sustains. The marginal economics matter: China-bound SKUs will likely carry lower ASPs and increased compliance costs, so revenue growth may not map 1:1 into gross-margin expansion; look for a few hundred-basis-point swing in blended data‑center margins depending on mix and channel discounts.

On the supply-chain side, the decision forces a rebalancing of scarce advanced-node wafer capacity. Any reallocation from next‑gen Rubin wafer starts to supply H200 demand creates a 6–12 month timing arbitrage: NVDA can buy sequenced revenue today at the expense of the cadence and scarcity premium for Rubin later, while TSM benefits volume now but risks obviating some high‑end pricing power if Rubin gets delayed.

Strategically, the move sets a precedent for transactional carve-outs in export policy — that reduces the probability of a permanent exclusion but raises binary tail risk from policy whiplash. The work-through to a sustained re-rate requires visible repeat orders over 2–3 quarters, margin accretion, and evidence of non-inventory-driven consumption (replacement/expansion), otherwise investor skepticism will keep the multiple range-bound.

Key Decisions for Investors

• Tactical call spread on NVDA to capture a near-term rerate: Buy 3–6 month ATM NVDA calls and sell 10–15% OTM calls (calendar/call spread) after the next shipment confirmation. Rationale: captures upside from confirmation of repeat orders while capping theta bleed; max loss = premium paid, target 1.5x–3x return if range breaks higher within 6 months.
• Core long with financed cost structure (multi-year): Buy NVDA Jan‑2027 LEAP calls (target strike ~10–20% OTM based on current price) and sell a series of short-dated calls (3–4 monthly cycles) to fund delta. Rationale: preserves upside to sustained AI TAM and Rubin delivery while monetizing near-term volatility; accept periodic assignment risk on short calls.
• Relative-value pair: long NVDA / short TSM (6–12 month horizon), equal dollar exposure adjusted for beta. Rationale: NVDA benefits from software/monetization leverage and margin optionality if orders prove recurring; TSM is cyclical and already priced for wafer-capacity normalization. Risk: if foundry tightness persists, TSM outperforms—size the short to limit portfolio drawdown to single-digit percent.
• Tail-risk hedge for policy reversal: Buy 3–9 month NVDA puts (10–15% OTM) or a cheap put calendar to protect against a sudden re-tightening of export controls. Rationale: policy whiplash remains the highest-probability binary that would compress multiple and force rapid derating; cost is insurance-worthy relative to notional exposure.